The New 3-Methyladenine Is Twice The Fun

All patients were at baseline status (no acute sickle event at least three weeks prior to sample collection). Spot urine samples were obtained so to as to minimize the burden on the patients and simulate routine screening at clinic visits. Blood samples were centrifuged at 4��C at 500g for 15 min to separate plasma. Plasma and urine samples were stored at ?80��C within 2 hr of collection until analysis. Urine osmolality was measured using a Freezing point osmometer (Advanced Instruments 3250, Norwood, MA). Plasma Cystatin C was measured by nephelometry using a clinical laboratory platform (BN ProSpec; Siemens Healthcare Diagnostics, www.medical.siemens.com). Inter- and intra-assay coefficients of variation were http://www.selleck.cn/products/3-methyladenine.html http://www.selleckchem.com/products/PF-2341066.html samples analyzed on the same day. The GFR was estimated from the cystatin C measurements using the following formula: GFR = antilog [1.962 + 1.123*log(1/cystatin C)], as described by Alvarez et al. [9]. Urine albumin was measured by immuno-turbidometry using Dimension Xpand clinical chemistry system (Siemens Healthcare Diagnostics, www.medical.siemens.com). Urinary levels of KIM-1 and NGAL (both from R&D systems, Minneapolis, MN), total TGF-�� (Millipore, Billerica, MA) and L-FABP (CMIC Co., Tokyo, Japan) were measured by enzyme linked immunosorbent assay (ELISA), as per manufacturers' instructions. For KIM-1 and NGAL ELISA, 50 ��l of sample was used per sample and each sample was analyzed in duplicates. For L-FABP assay 50 ��l of samples were pretreated with the provided reagent. Totally, 20 ��l of pretreated samples were then used in the assay in duplicates. Urine NAG activity was measured using a colorimetric assay (Roche Diagnostics, USA). Briefly, 5 ��l of sample was incubated with 100 ��l of substrate solution (3-Cresolsulfonphthaleinyl-N-acetyl-b-D-glucosaminide) for 20 min at 37��C. The reaction was stopped with a stop solution containing sodium carbonate and the optical density (OD) measured at 580 nm. The OD values were subtracted from blank and NAG activity was calculated and the activity was expressed in units per liter (U/L). Urine active TFG-�� was measured using an ELISA kit (R&D systems), as per the manufacturer's instructions. Briefly 100 ��l of urine http://www.selleckchem.com/products/r428.html samples were treated with 20 ��l 1N HCl for 20 min. The samples were then neutralized with 20 ��l of 1N NaOH/0.5M HEPES (pH 7.5). All urinary biomarker levels were normalized with urine creatinine. Urine Creatinine was measured using an alkaline picrate assay (R&D systems). All urinary biomarkers were expressed as a ratio of urine creatinine. We used summary statistics: mean, standard errors, frequencies and range and ANOVA using the GraphPad Prism software, version 5.0, to summarize the clinical and hematological/ renal parameter characteristics of the current cohort of sickle cell disease patients in Tables I and II.